Hannah Brendan

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
7 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Hannah Brendan's trades of Quince Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
289.87
Quantity 26,479 +46.2%
Value US$1,301,792
Transaction date
Purchase
Price
238.90
Quantity 94,553 -32.4%
Value US$4,737,652
Transaction date
Purchase
Price
66.37
Quantity 52,614 -32.9%
Value US$749,087
Transaction date
Purchase
Price
0.60
Quantity 3,424 +1.3%
Value US$2,054
Transaction date
Purchase
Price
0.61
Quantity 2,500 +1.0%
Value US$1,525
Transaction date
Purchase
Price
0.58
Quantity 2,155 +0.8%
Value US$1,250
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-21 2024-08-21
B Purchase
26,479 +46.2%
289.87
US$1,301,792 		26,479 +46.2% 289.87 US$1,301,792
2024-08-21 2024-08-21
B Purchase
94,553 -32.4%
238.90
US$4,737,652 		94,553 -32.4% 238.90 US$4,737,652
2024-08-21 2024-08-21
B Purchase
52,614 -32.9%
66.37
US$749,087 		52,614 -32.9% 66.37 US$749,087
2024-08-21 2024-08-20
B Purchase
3,424 +1.3%
0.60
US$2,054 		3,424 +1.3% 0.60 US$2,054
2024-08-21 2024-08-20
B Purchase
2,500 +1.0%
0.61
US$1,525 		2,500 +1.0% 0.61 US$1,525
2024-08-21 2024-08-19
B Purchase
2,155 +0.8%
0.58
US$1,250 		2,155 +0.8% 0.58 US$1,250
2023-08-09 2023-08-08
B Purchase
71,762 +55.3%
1.22
US$87,550 		71,762 +55.3% 1.22 US$87,550